![Page 1: AD-4/ACE Status Report CERN, 21 th November 2006 Niels Bassler](https://reader036.vdocuments.mx/reader036/viewer/2022062807/56815161550346895dbf8793/html5/thumbnails/1.jpg)
AD-4/ACE Status ReportCERN, 21th November 2006
Niels Bassler
Dept. Clinical Experimental Oncology, Aarhus University Hospitaland
Deutsches Krebsforschungszenrum, Heidelberg
![Page 2: AD-4/ACE Status Report CERN, 21 th November 2006 Niels Bassler](https://reader036.vdocuments.mx/reader036/viewer/2022062807/56815161550346895dbf8793/html5/thumbnails/2.jpg)
2
Radiotherapy
The Quest:
Hit the tumour, save the surrounding tissue!
![Page 3: AD-4/ACE Status Report CERN, 21 th November 2006 Niels Bassler](https://reader036.vdocuments.mx/reader036/viewer/2022062807/56815161550346895dbf8793/html5/thumbnails/3.jpg)
3
PROTON THERAPY
![Page 4: AD-4/ACE Status Report CERN, 21 th November 2006 Niels Bassler](https://reader036.vdocuments.mx/reader036/viewer/2022062807/56815161550346895dbf8793/html5/thumbnails/4.jpg)
4
PROTON THERAPYx-rays
protons
![Page 5: AD-4/ACE Status Report CERN, 21 th November 2006 Niels Bassler](https://reader036.vdocuments.mx/reader036/viewer/2022062807/56815161550346895dbf8793/html5/thumbnails/5.jpg)
5
PROTON THERAPYx-rays
protons
![Page 6: AD-4/ACE Status Report CERN, 21 th November 2006 Niels Bassler](https://reader036.vdocuments.mx/reader036/viewer/2022062807/56815161550346895dbf8793/html5/thumbnails/6.jpg)
6
IMRT vs. IMPT Treatment Plans
(Weber et al.)
x-rays protons
![Page 7: AD-4/ACE Status Report CERN, 21 th November 2006 Niels Bassler](https://reader036.vdocuments.mx/reader036/viewer/2022062807/56815161550346895dbf8793/html5/thumbnails/7.jpg)
7
IMRT vs. IMPT vs. IMAT Treatment Plans
(Weber et al.)
x-rays protons
![Page 8: AD-4/ACE Status Report CERN, 21 th November 2006 Niels Bassler](https://reader036.vdocuments.mx/reader036/viewer/2022062807/56815161550346895dbf8793/html5/thumbnails/8.jpg)
8
ANTIPROTON THERAPY ?
![Page 9: AD-4/ACE Status Report CERN, 21 th November 2006 Niels Bassler](https://reader036.vdocuments.mx/reader036/viewer/2022062807/56815161550346895dbf8793/html5/thumbnails/9.jpg)
9
ANTIPROTONS
(FLUKA Calculation)
The idea ...
![Page 10: AD-4/ACE Status Report CERN, 21 th November 2006 Niels Bassler](https://reader036.vdocuments.mx/reader036/viewer/2022062807/56815161550346895dbf8793/html5/thumbnails/10.jpg)
10
Antiproton Annihilation
Energy from annihilation : 2x mp ~ 1.88 GeV
Most of the energy is carried away by pions and gammas. Recoiling nuclei do the local damage, “only” about 30 MeV
pions Gamma-rays
neutronsNuclei (fragments)
![Page 11: AD-4/ACE Status Report CERN, 21 th November 2006 Niels Bassler](https://reader036.vdocuments.mx/reader036/viewer/2022062807/56815161550346895dbf8793/html5/thumbnails/11.jpg)
11
GAFChromic Film Irradiation
Antiprotons (3 different energies)CERN – 2003
Protons (3 different energies)ASTRID, Århus, DK.
![Page 12: AD-4/ACE Status Report CERN, 21 th November 2006 Niels Bassler](https://reader036.vdocuments.mx/reader036/viewer/2022062807/56815161550346895dbf8793/html5/thumbnails/12.jpg)
12
Radiobiology
Dose is not everything!
There is also Radiobiology:
High-LET radiation do more cell damage for the same physical dose -> higher Relative Biological Efficiency (RBE)
Due to the high LET behaviour in the antiproton peak it is not sufficient to consider physical dose alone, when doing the treatment plan.
RBE must be modeled in the treatment plan as well, since it depends on particle type, energy, tissue type etc..
![Page 13: AD-4/ACE Status Report CERN, 21 th November 2006 Niels Bassler](https://reader036.vdocuments.mx/reader036/viewer/2022062807/56815161550346895dbf8793/html5/thumbnails/13.jpg)
13
Therefore the Radiobiology of the Antiproton beam was investigated at CERN:
![Page 14: AD-4/ACE Status Report CERN, 21 th November 2006 Niels Bassler](https://reader036.vdocuments.mx/reader036/viewer/2022062807/56815161550346895dbf8793/html5/thumbnails/14.jpg)
14
The AD4/ACE Experiment at CERN
SCINTILLATOR (1 of 2)
CCD CAMERA
BEAM CURRENT MONITORWATER PHANTOM
TARGETBEAM
DEGRADER
![Page 15: AD-4/ACE Status Report CERN, 21 th November 2006 Niels Bassler](https://reader036.vdocuments.mx/reader036/viewer/2022062807/56815161550346895dbf8793/html5/thumbnails/15.jpg)
15
AD4/ACE - The Test Tube
Chinese V79 Hamster Cells suspended in gelatine solution.
Cooled to a few °C to stop cell repairing.
After irradiation, slices of 0.5-1 mm are plated on Petri-dishes, and the colonies are counted.
![Page 16: AD-4/ACE Status Report CERN, 21 th November 2006 Niels Bassler](https://reader036.vdocuments.mx/reader036/viewer/2022062807/56815161550346895dbf8793/html5/thumbnails/16.jpg)
17
CERN Results
(CERN data from 2003)
![Page 17: AD-4/ACE Status Report CERN, 21 th November 2006 Niels Bassler](https://reader036.vdocuments.mx/reader036/viewer/2022062807/56815161550346895dbf8793/html5/thumbnails/17.jpg)
18
Relative Biological Efficiency (RBE)
Usually one would then measure the RBE (in the plateau and the peak) for antiprotons..
BUT : it is not possible to determine the RBE if the physical dose is unknown !Antiprotons have a mixed particle field, difficult to measure.(Ionization chambers were thought to be unusable...)RBE =
DCo60
DPBarsfor iso-effect
![Page 18: AD-4/ACE Status Report CERN, 21 th November 2006 Niels Bassler](https://reader036.vdocuments.mx/reader036/viewer/2022062807/56815161550346895dbf8793/html5/thumbnails/18.jpg)
19
Relative Biological Efficiency (RBE)
Usually one would then measure the RBE (in the plateau and the peak) for antiprotons..
BUT : it is not possible to determine the RBE if the physical dose is unknown !Antiprotons have a mixed particle field, difficult to measure.(Ionization chambers were thought to be unusable...)RBE =
DCo60
DPBars
?for iso-effect
![Page 19: AD-4/ACE Status Report CERN, 21 th November 2006 Niels Bassler](https://reader036.vdocuments.mx/reader036/viewer/2022062807/56815161550346895dbf8793/html5/thumbnails/19.jpg)
20
Biological Effective Dose Ratio (BEDR)
BiologyPhysics
( F : physical dose ratio between peak and plateau. )
BEDR : New parameter which can be measured.
BEDR describes dose ratio for peak/plateau for iso-effect.
(Any number proportional to the fluence)
(CERN data from 2003)
![Page 20: AD-4/ACE Status Report CERN, 21 th November 2006 Niels Bassler](https://reader036.vdocuments.mx/reader036/viewer/2022062807/56815161550346895dbf8793/html5/thumbnails/20.jpg)
21
Biological Effective Dose Ratio (BEDR)
BEDR for antiprotons : ~ 9.8
BEDR for protons (TRIUMF) : ~ 2.5
=> antiprotons may be 9.8/2.5 ~ 4 times more effective in reducing the the damage to normal tissue for the same peak dose, relative to a similar degraded proton beam...
=> antiprotons may be 9.8/2.5 ~ 4 times more effective in reducing the the damage to normal tissue for the same peak dose, relative to a similar degraded proton beam...
![Page 21: AD-4/ACE Status Report CERN, 21 th November 2006 Niels Bassler](https://reader036.vdocuments.mx/reader036/viewer/2022062807/56815161550346895dbf8793/html5/thumbnails/21.jpg)
22
Biological Effective Dose Ratio (BEDR)
BEDR for antiprotons : ~ 9.8
BEDR for protons (TRIUMF) : ~ 2.5
=> antiprotons may be 9.8/2.5 ~ 4 times more effective in reducing the the damage to normal tissue for the same peak dose, relative to a similar degraded proton beam...
=> antiprotons may be 9.8/2.5 ~ 4 times more effective in reducing the the damage to normal tissue for the same peak dose, relative to a similar degraded proton beam...
Findings were recently published in “Radiotherapy and Oncology”
Radiother Oncol (2006), doi:10.1016/j.radonc.2006.09.012
![Page 22: AD-4/ACE Status Report CERN, 21 th November 2006 Niels Bassler](https://reader036.vdocuments.mx/reader036/viewer/2022062807/56815161550346895dbf8793/html5/thumbnails/22.jpg)
23
ANTIPROTON DOSIMETRY
BEDR is nice, but sooner or later the RBE must be measured.
Therefore dosimetry in the annihilation peak is inevitable.
Dosimetry in the plateau is easier, since antiprotons behave as protons at high velocities.
![Page 23: AD-4/ACE Status Report CERN, 21 th November 2006 Niels Bassler](https://reader036.vdocuments.mx/reader036/viewer/2022062807/56815161550346895dbf8793/html5/thumbnails/23.jpg)
24
ANTIPROTON DOSIMETRY
Purpose: 1) Estimate dose in peak region
2) If possible derive information about particle spectrum in annihilation peak
3) Estimate peripheral damage (neutrons)
IN ANNIHILATION VERTEX: Thermoluminescent Detectors
(TLD) Alanine GAFChromic Film
IN PERIPHERAL REGION: Thermoluminescent Detectors
(TLD) Neutron Bubble Detectors
![Page 24: AD-4/ACE Status Report CERN, 21 th November 2006 Niels Bassler](https://reader036.vdocuments.mx/reader036/viewer/2022062807/56815161550346895dbf8793/html5/thumbnails/24.jpg)
25
ANTIPROTON DOSIMETRY
IN ANNIHILATION VERTEX: Thermoluminescent Detectors
(TLD) Alanine GAFChromic Film
IN PERIPHERAL REGION: Thermoluminescent Detectors
(TLD) Neutron Bubble Detectors
TLDs7LiF and 6LiF
Alanine
GAFChromic Film
Bubble detectors
![Page 25: AD-4/ACE Status Report CERN, 21 th November 2006 Niels Bassler](https://reader036.vdocuments.mx/reader036/viewer/2022062807/56815161550346895dbf8793/html5/thumbnails/25.jpg)
26
Dosimetry
TLDs and Alanine respond highly non-linear to high-LET radiation.Response is depending on particle energy, charge, mass, fluence.And even experimental findings of efficiencies are ambiguous!
TLD – entire signal Alanine
![Page 26: AD-4/ACE Status Report CERN, 21 th November 2006 Niels Bassler](https://reader036.vdocuments.mx/reader036/viewer/2022062807/56815161550346895dbf8793/html5/thumbnails/26.jpg)
28
Dosimetry – Detector Efficiency Models
A track structure model (by Hansen et al.) were used for estimating Alanine response.
For estimating the TLD response in the antiproton beam the ECLaT model (based on the Local Effect Model) was applied.
Track structure models can possibly be applied to GAFChromic Films as well.
The Local Effect Model (LEM) is being used by GSI and DKFZ to predict RBEs of various cell lines in mixed particle field from Carbon ion beams with some success.
![Page 27: AD-4/ACE Status Report CERN, 21 th November 2006 Niels Bassler](https://reader036.vdocuments.mx/reader036/viewer/2022062807/56815161550346895dbf8793/html5/thumbnails/27.jpg)
29
Comparison of Calculations and Measurements
New results from CERN - 2003 & 2004 run.
![Page 28: AD-4/ACE Status Report CERN, 21 th November 2006 Niels Bassler](https://reader036.vdocuments.mx/reader036/viewer/2022062807/56815161550346895dbf8793/html5/thumbnails/28.jpg)
30
Comparison of Calculations and Measurements
New results from CERN - 2003 & 2004 run.
![Page 29: AD-4/ACE Status Report CERN, 21 th November 2006 Niels Bassler](https://reader036.vdocuments.mx/reader036/viewer/2022062807/56815161550346895dbf8793/html5/thumbnails/29.jpg)
31
Peripheral Results
With TLDs the contribution from gammas, protons and pions were measured, as well as thermal neutrons.
Results (here shown per 10^7 pbars) indicate similar dose contribution as seen with proton therapy using a passive degrader.
New results from CERN - 2003 & 2004 run.
![Page 30: AD-4/ACE Status Report CERN, 21 th November 2006 Niels Bassler](https://reader036.vdocuments.mx/reader036/viewer/2022062807/56815161550346895dbf8793/html5/thumbnails/30.jpg)
32
The central question we now want to have answered is:
What clinical results could be expected from antiproton therapy based on these observations?
Currently, the only way to give a proper answer to this question is to perform planning studies for several real cases with Antiprotons and compare with that of X-rays, protons and carbon ions.
For implementing antiprotons in a treatment planning system (TPS), exact knowledge of the dose and biology of the antiproton beam is vital.
This is happening at the DKFZ – the “TRiP98” TPS is going to be modified. Unlike conventional proton treatment planning software, TRiP includes a biology model (LEM).
Simultaneously, GEANT with the biological module is investigated.
![Page 31: AD-4/ACE Status Report CERN, 21 th November 2006 Niels Bassler](https://reader036.vdocuments.mx/reader036/viewer/2022062807/56815161550346895dbf8793/html5/thumbnails/31.jpg)
33
OCTOBER 2006 EXPERIMENTSStatus
![Page 32: AD-4/ACE Status Report CERN, 21 th November 2006 Niels Bassler](https://reader036.vdocuments.mx/reader036/viewer/2022062807/56815161550346895dbf8793/html5/thumbnails/32.jpg)
34
October 2006 – New Experiments
Main feature this year:
Increased energy - 125 MeV instead of 46 MeV as in 2003/2004. => larger penetration depth (~10 cm instead of ~2 cm)
1) more precise study of the effects from inflight annihilation (!)
2) better seperation of peak/plateau
3) more energy straggling => natural increased width of peak
4) possibility of generating a 1 cm SOBP
![Page 33: AD-4/ACE Status Report CERN, 21 th November 2006 Niels Bassler](https://reader036.vdocuments.mx/reader036/viewer/2022062807/56815161550346895dbf8793/html5/thumbnails/33.jpg)
35
October 2006 – New Experiments
DOSIMETRY
primarily addressing the in-flight annihilation question
Ionization chamber measurements
Two Alanine stacks irradiated
GAFChromic Film Irradiation (HS + EBT)
BIOLOGY
Survival Curves (Clonogenic assay)
>New< : Genetic expression experiment
![Page 34: AD-4/ACE Status Report CERN, 21 th November 2006 Niels Bassler](https://reader036.vdocuments.mx/reader036/viewer/2022062807/56815161550346895dbf8793/html5/thumbnails/34.jpg)
36
Ionization chamber measurement in water target.
Earlier thought to be impossible
Boag's two-voltage method applied to correct for general recombination. (eff. corr 1-0.8 !)
![Page 35: AD-4/ACE Status Report CERN, 21 th November 2006 Niels Bassler](https://reader036.vdocuments.mx/reader036/viewer/2022062807/56815161550346895dbf8793/html5/thumbnails/35.jpg)
37
Oct. 2006 - Results of Ionization Chamber Measurements
Data presented here are relative. Calibration of chamber scheduled within next weeks.
![Page 36: AD-4/ACE Status Report CERN, 21 th November 2006 Niels Bassler](https://reader036.vdocuments.mx/reader036/viewer/2022062807/56815161550346895dbf8793/html5/thumbnails/36.jpg)
38
Oct. 2006 - Results of Ionizationchamber Measurements
Comparison with FLUKA and SHIELD-HIT MC code.
SHIELD-HIT v. 2.2
Slight overestimation of peak dose.
Presumably underestimation of inflight annihilation.
![Page 37: AD-4/ACE Status Report CERN, 21 th November 2006 Niels Bassler](https://reader036.vdocuments.mx/reader036/viewer/2022062807/56815161550346895dbf8793/html5/thumbnails/37.jpg)
39
Oct. 2006 - Results of Ionizationchamber Measurements
FLUKA 2006.3
Success! Very satisfying result!
![Page 38: AD-4/ACE Status Report CERN, 21 th November 2006 Niels Bassler](https://reader036.vdocuments.mx/reader036/viewer/2022062807/56815161550346895dbf8793/html5/thumbnails/38.jpg)
40
Oct. 2006 - Alanine Irradiation
Alternative dosimeter, in case of ionization chamber failed.
Test of response model and particle spectrum from particle annihilation.
Dose -> Response calculation not yet performed. (will use Johnny model)
![Page 39: AD-4/ACE Status Report CERN, 21 th November 2006 Niels Bassler](https://reader036.vdocuments.mx/reader036/viewer/2022062807/56815161550346895dbf8793/html5/thumbnails/39.jpg)
41
Oct. 2006 - GAFChromic Film Irradiation
Films are not analyzed yet.
An alternative dosimeter with different LET response.
Additional dose verification, (and on site beam verification)
![Page 40: AD-4/ACE Status Report CERN, 21 th November 2006 Niels Bassler](https://reader036.vdocuments.mx/reader036/viewer/2022062807/56815161550346895dbf8793/html5/thumbnails/40.jpg)
42
Oct. 2006 – Biology BEDR/RBE Measurements
Analysis in progress, as dose delivered is not yet known.
PRISTINE SOBP
(MAASTRO, University of Maastricht)
![Page 41: AD-4/ACE Status Report CERN, 21 th November 2006 Niels Bassler](https://reader036.vdocuments.mx/reader036/viewer/2022062807/56815161550346895dbf8793/html5/thumbnails/41.jpg)
43
Oct. 2006 – Biology Gene Expression Experiment
Genetic expression study of a human cell line (FaDu)
SOBP used (clinical relevance)
Slices from the Bragg-peak and a slice from the plateau have been prepared.
Qualititive experiment (understand why is RBE higher)
(Dept. of Clinical Oncology at the University Hospital in Aarhus.)
![Page 42: AD-4/ACE Status Report CERN, 21 th November 2006 Niels Bassler](https://reader036.vdocuments.mx/reader036/viewer/2022062807/56815161550346895dbf8793/html5/thumbnails/42.jpg)
44
Summary
Antiprotons seem ~4 times more effective delivering the dose in the peak region than protons or in other words: normal tissue dose could be reduced ~4 times for the same target dose.
FLUKA was benchmarked and will most likely be the preferred choice for Monte Carlo simulation of Antiproton annihilation.
This dataset will be used for implementing antiprotons in treatment planning system, and benchmarking it.
![Page 43: AD-4/ACE Status Report CERN, 21 th November 2006 Niels Bassler](https://reader036.vdocuments.mx/reader036/viewer/2022062807/56815161550346895dbf8793/html5/thumbnails/43.jpg)
45
Outlook
RBEs can very soon be extracted, based on experimentally verified MC simulations.
Heavy-ion treatment planning system TRiP from DKFZ/GSI will be modified to support antiprotons.
Further investigation of the far peripheral damage – (stochastic effects.)
Further investigation of the biological effect in the immediate surrounding of the beam (i.e. “the tail”).
We will then be able to evaluate the clinical potential of antiproton therapy.